Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Alcohol Dependence
NCT02771925Phase 4Terminated
- Sponsor
- Dayanand Medical College & Hospital
- Start
- Jun 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol dependence comparing Gabapentin with Placebo (2 arms). Primary endpoint: Rate of no Heavy Episodic Drinking over 6 month. Started Jun 2016; status: terminated.
02
Drugs
gabapentin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT02771925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771925.